DeepMed Research

UNIVERSITY OF ARIZONA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-01-01

Employees: 10K

Market Cap: -

Website: http://www.arizona.edu

Clinical Trials

Immune Response to the COVID-19 Vaccine

Early Phase 1

Completed

Conditions: Cancer
Malignancy
Covid19
Vaccine Response Impaired

Interventions: Biological: SARS-COV2 Pfizer Vaccine

First Posted Date: 2021-06-23

Last Posted Date: 2022-05-20

Lead Sponsor: University of Arizona

Target Recruit Count: 20

Registration Number: NCT04936997

Locations: 🇺🇸
University of Arizona, Tucson, Arizona, United States

Treatment of Tinnitus With Noninvasive Neuromodulation and Listening Therapy

Not Applicable

Not yet recruiting

Conditions: Hyperacusis
Tinnitus, Subjective
Hearing Disorders

Interventions: Device: Transcranial Direct Current Stimulation (tDCS)
Device: Sham TDCS

First Posted Date: 2021-06-22

Last Posted Date: 2024-05-08

Lead Sponsor: University of Arizona

Target Recruit Count: 30

Registration Number: NCT04934371

Locations: 🇺🇸
University of Arizona, Tucson, Arizona, United States

Breathing Training for Improving Cardiovascular Health in Older Adults With Sleep Apnea

Not Applicable

Recruiting

Conditions: Obstructive Sleep Apnea
Hypertension

Interventions: Behavioral: Inspiratory Muscle Strength Training

First Posted Date: 2021-06-21

Last Posted Date: 2025-04-04

Lead Sponsor: University of Arizona

Target Recruit Count: 122

Registration Number: NCT04932447

Locations: 🇺🇸
Arizona Respiratory and Neurophysiology Laboratory, Tucson, Arizona, United States

Enhancing Language Function in Primary Progressive Aphasia

Not Applicable

Recruiting

Conditions: Primary Progressive Aphasia

Interventions: Combination Product: tDCS + language therapy
Combination Product: sham TDCS + language therapy

First Posted Date: 2021-06-09

Last Posted Date: 2024-11-28

Lead Sponsor: University of Arizona

Target Recruit Count: 20

Registration Number: NCT04920318

Locations: 🇺🇸
University of Arizona, Tucson, Arizona, United States

Gallbladder Cryoablation in High-Risk Patients

Not Applicable

Conditions: Gallstone; Cholecystitis
Biliary Colic
Gallbladder Diseases
Cholecystitis
Gallstone
Gall Bladder Pain
Biliary Dyskinesia

Interventions: Device: Gallbladder Cryoablation

First Posted Date: 2021-06-07

Last Posted Date: 2021-06-07

Lead Sponsor: University of Arizona

Target Recruit Count: 20

Registration Number: NCT04915651

Locations: 🇺🇸
University of Arizona, Tucson, Arizona, United States

CDDOM Oneome Rightmed Depression Study

Not Applicable

Conditions: Depression, Anxiety

Interventions: Genetic: Oneome RightMEd Pharmacogenomic testing Kit

First Posted Date: 2021-06-02

Last Posted Date: 2021-06-02

Lead Sponsor: University of Arizona

Target Recruit Count: 350

Registration Number: NCT04909749

Efficacy of Personal Pharmacogenomic Testing as an Educational Tool in the Pharmacy Curriculum

Not Applicable

Completed

Conditions: Healthy

Interventions: Genetic: Personal genomic educational testing (PGET)
Genetic: No personal genomic educational testing (NPGET)

First Posted Date: 2021-05-17

Last Posted Date: 2021-05-17

Lead Sponsor: University of Arizona

Target Recruit Count: 233

Registration Number: NCT04889014

Pre-operative Tamsulosin and Time to Spontaneous Void After Hysterectomy

Phase 2

Completed

Conditions: Urinary Retention Postoperative

Interventions: Drug: Tamsulosin
Drug: Placebo

First Posted Date: 2021-04-26

Last Posted Date: 2024-02-29

Lead Sponsor: University of Arizona

Target Recruit Count: 161

Registration Number: NCT04859660

Locations: 🇺🇸
Banner University Medical Center- Phoenix, Phoenix, Arizona, United States
🇺🇸
Banner University Medical Center- Tucson, Tucson, Arizona, United States

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

Phase 2

Recruiting

Conditions: Alzheimer Dementia
Neurodegenerative Diseases
Late Onset Alzheimer Disease

Interventions: Drug: Allopregnanolone
Other: Placebo

First Posted Date: 2021-04-09

Last Posted Date: 2025-05-11

Lead Sponsor: University of Arizona

Target Recruit Count: 200

Registration Number: NCT04838301

Locations: 🇺🇸
Perseverance Research Center, Scottsdale, Arizona, United States
🇺🇸
ATP Clinical Research, Costa Mesa, California, United States
🇺🇸
Syrentis Clinical Research, Santa Ana, California, United States

and more 5 locations

Atezolizumab + Cabozantinib in Patients W/ Metastatic, Refractory Pancreatic Cancer

Phase 2

Recruiting

Conditions: Pancreatic Cancer
Metastatic Pancreatic Cancer

Interventions: Drug: Cabozantinib + Atezolizumab

First Posted Date: 2021-03-29

Last Posted Date: 2025-03-27

Lead Sponsor: University of Arizona

Target Recruit Count: 29

Registration Number: NCT04820179

Locations: 🇺🇸
University of Arizona Cancer Center, Tucson, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy